Article,
Assessing the role of phosphorylated S6 ribosomal protein in the pathological diagnosis of pulmonary antibody-mediated rejection
Affiliations
- [1] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy [NORA names: Italy; Europe, EU; OECD];
- [2] Grp Hosp Marie Lannelongue Paris St Joseph, Serv Pneumol & Transplantat Plum, Le Plessis Robinson, France [NORA names: France; Europe, EU; OECD];
- [3] Univ Paris Sud, INSERM, Grp Hosp Marie Lannelongue St Joseph, UMR S 999, Le Plessis Robinson, France [NORA names: France; Europe, EU; OECD];
- [4] Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France [NORA names: France; Europe, EU; OECD];
- [5] Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France [NORA names: France; Europe, EU; OECD];
(... more)
Abstract
Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.
Keywords
antibody-mediated rejection,
antibody-mediated rejection (AMR),
lung transplantation,
mammalian target of rapamycin (mTOR) pathway,
phosphorylated s6 ribosomal protein (p-S6RP)